Optimizing Early Nutrition Support in Severe Stroke-2

Status Recruiting

Clinical Trial Summary

Post stroke pneumonia (PSP) is one of the common early complications of stroke. Post-stroke infections, in general, are associated with less favorable neurologic outcomes. Aspiration is one of the most feared complications of enteral nutrition and can lead to the occurrence of pneumonia. Severe stroke patients are at high risk for aspiration due to some factors such as the reduced level of consciousness, inability to protect the airway and so on. The purpose of this study is to explore the ideal nutrition support strategy for patient with acute severe stroke to help reduce the incidence of PSP and improve the prognosis.

Clinical Trial Description

As one of the most common complication of stroke, some studies showed that post-stroke pneumonia (PSP) in stroke patients requiring intensive care is associated with an increase of ICU length of stay and hospital mortality and poorer functional outcomes in survivors. The peak period of PSP is within the first week after stroke. Aspiration and poor nutritional status are important factors leading to pneumonia in stroke patients. Compared with full enteral nutrition (EN), initial trophic enteral feeding was associated with less gastrointestinal intolerance and could reduce the rate of regurgitation. However, trophic enteral feeding could not meet the daily caloric needs and hypocaloric enteral nutrition might be associated with increased mortality. This study is designed to explore whether initial trophic enteral nutrition combined with supplemental parenteral nutrition (SPN) can help reduce the incidence of PSP and improve the prognosis in severe patients with stroke. This study will enroll 546 severe stroke patients who meet the inclusion criteria. Upon admission to the ICU, patients will be randomly assigned at a 1:1 ratio into groups of full enteral feeding (controlled) and trophic enteral feeding combined with supplemental parenteral feeding (experimented) for 7 days. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05998902
Study type	Interventional
Source	Xijing Hospital
Contact	Wen Jiang, Ph.D
Phone	86-029-84771319
Email	jiangwen@fmmu.edu.cn
Status	Recruiting
Phase	Phase 3
Start date	December 20, 2023
Completion date	October 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03711474` - Dysphagia Following Anterior Cervical Spine Surgery; Single Dose Steroid vs Saline (DysDexVSSal)	Phase 4
Enrolling by invitation	`NCT04074356` - Non-invasive Markers of Esophageal Function in Adults	N/A
Suspended	`NCT04349462` - Post Critical Illness Dysphagia in the Intensive Care Unit	N/A
Not yet recruiting	`NCT05982977` - Study on the Effect Mechanism of Acupuncture Combined With Swallowing Training in Oral Dysphagia of Stroke	N/A
Recruiting	`NCT03605381` - MORbidity PRevalence Estimate In StrokE
Active, not recruiting	`NCT03455608` - PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer	N/A
Active, not recruiting	`NCT03604822` - Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS	N/A
Recruiting	`NCT03682081` - Interventions for Patients With Alzheimer's Disease and Dysphagia	N/A
Completed	`NCT05700838` - Refining Cough Skill Training in Parkinson's Disease and Dysphagia	Phase 1
Not yet recruiting	`NCT04064333` - Slow-Stream Expiratory Muscle Strength Training for Veterans With Dysphagia Living in Long-term Care	N/A
Not yet recruiting	`NCT02724761` - Prophylactic Racemic Epinephrine in Anterior Cervical Discectomy and Fusion	N/A
Completed	`NCT02927691` - Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial	Phase 2
Completed	`NCT01919112` - Fostering Eating After Stroke With Transcranial Direct Current Stimulation	N/A
Completed	`NCT01370083` - Tongue Pressure Profile Training for Dysphagia Post Stroke	Phase 2
Withdrawn	`NCT01200147` - Effectiveness of Rupture of Schatzki's Ring Using Biopsy Forceps Versus SIngle Dilation	N/A
Completed	`NCT01723358` - Neuromuscular Electrical Stimulation (NMES) Treatment Technique Therapy in the Management of Young Infants With Severe Dysphagia	Phase 2
Completed	`NCT00570557` - Development of a Web-Based Course to Maintain Skills in Nurses Trained to Screen for Dysphagia	N/A
Recruiting	`NCT00166751` - Sonographic Assessment of Laryngeal Elevation	N/A
Completed	`NCT00717028` - Functional Endoscopic Evaluation of Swallowing	N/A
Completed	`NCT01476241` - Percutaneous Endoscopic Gastrostomy Tube Placement by Otorhinolaryngologist	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.